Munich Reinsurance Co Stock Corp in Munich Sells 4,976 Shares of Lam Research Corporation $LRCX

Munich Reinsurance Co Stock Corp in Munich reduced its stake in Lam Research Corporation (NASDAQ:LRCXFree Report) by 10.6% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 42,175 shares of the semiconductor company’s stock after selling 4,976 shares during the period. Munich Reinsurance Co Stock Corp in Munich’s holdings in Lam Research were worth $18,276,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in LRCX. World Equity Group Inc. raised its position in shares of Lam Research by 0.5% in the 2nd quarter. World Equity Group Inc. now owns 5,576 shares of the semiconductor company’s stock valued at $2,416,000 after acquiring an additional 29 shares during the period. Tenzing Financial LLC grew its holdings in Lam Research by 3.5% during the second quarter. Tenzing Financial LLC now owns 1,018 shares of the semiconductor company’s stock valued at $441,000 after purchasing an additional 34 shares during the period. Gibraltar Capital Management Inc. grew its holdings in Lam Research by 3.6% during the second quarter. Gibraltar Capital Management Inc. now owns 1,050 shares of the semiconductor company’s stock valued at $455,000 after purchasing an additional 36 shares during the period. Elevated Financial Group LLC increased its stake in Lam Research by 3.0% in the second quarter. Elevated Financial Group LLC now owns 1,223 shares of the semiconductor company’s stock valued at $530,000 after purchasing an additional 36 shares in the last quarter. Finally, Yoder Wealth Management Inc. increased its stake in Lam Research by 3.3% in the second quarter. Yoder Wealth Management Inc. now owns 1,129 shares of the semiconductor company’s stock valued at $489,000 after purchasing an additional 36 shares in the last quarter. 84.61% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on LRCX shares. Zacks Research raised shares of Lam Research from a “hold” rating to a “strong-buy” rating in a research report on Friday, July 17th. Weiss Ratings raised Lam Research from a “buy (b-)” rating to a “buy (b)” rating in a research note on Friday. HSBC reissued a “hold” rating and issued a $333.00 target price on shares of Lam Research in a research note on Monday, July 27th. Mizuho increased their price target on Lam Research from $380.00 to $400.00 and gave the stock an “outperform” rating in a report on Thursday, July 9th. Finally, Rothschild & Co Redburn raised their price target on Lam Research from $305.00 to $420.00 and gave the stock a “buy” rating in a research report on Wednesday, June 17th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-six have issued a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $358.47.

Read Our Latest Stock Report on LRCX

Insider Activity at Lam Research

In other Lam Research news, SVP Neil J. Fernandes sold 7,659 shares of the firm’s stock in a transaction that occurred on Monday, June 1st. The stock was sold at an average price of $309.60, for a total value of $2,371,226.40. Following the completion of the transaction, the senior vice president directly owned 58,470 shares in the company, valued at $18,102,312. This trade represents a 11.58% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Eric Brandt sold 54,500 shares of the business’s stock in a transaction that occurred on Thursday, June 11th. The stock was sold at an average price of $350.80, for a total value of $19,118,600.00. Following the transaction, the director directly owned 199,205 shares in the company, valued at $69,881,114. This trade represents a 21.48% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders have sold 80,441 shares of company stock valued at $27,614,296. 0.31% of the stock is owned by insiders.

Lam Research Stock Performance

Shares of LRCX stock opened at $314.00 on Monday. Lam Research Corporation has a 12 month low of $94.11 and a 12 month high of $438.50. The company’s fifty day simple moving average is $337.47 and its 200-day simple moving average is $286.43. The firm has a market cap of $392.91 billion, a PE ratio of 54.51, a P/E/G ratio of 1.25 and a beta of 1.84. The company has a quick ratio of 1.91, a current ratio of 2.63 and a debt-to-equity ratio of 0.30.

Lam Research (NASDAQ:LRCXGet Free Report) last issued its quarterly earnings results on Wednesday, July 29th. The semiconductor company reported $1.82 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.69 by $0.13. Lam Research had a net margin of 31.27% and a return on equity of 67.60%. The firm had revenue of $6.72 billion for the quarter, compared to analyst estimates of $6.66 billion. During the same period in the previous year, the business earned $1.33 EPS. The company’s revenue was up 30.0% compared to the same quarter last year. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. Equities research analysts expect that Lam Research Corporation will post 9.32 EPS for the current fiscal year.

Lam Research Company Profile

(Free Report)

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.

Featured Stories

Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCXFree Report).

Institutional Ownership by Quarter for Lam Research (NASDAQ:LRCX)

Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.